Environmental Control as Add-on Therapy in Childhood Asthma
Status:
Completed
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
This study evaluates the effects of adding on an environmental home intervention to standard
asthma medication management on controller medication requirements among children and
adolescents with asthma. The investigators hypothesize that the addition of an
individually-tailored, multi-faceted Environmental Control Strategy (ECS) to guidelines-based
controller medication will result in less controller medication requirement and allergic
inflammation than controller medication alone among urban asthmatic children.
Phase:
Phase 2
Details
Lead Sponsor:
Johns Hopkins University
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination Xhance